knowledge -WSS

knowledge

author：Wikipedia 2025-09-06 20:46:15 - browse：639

1:43Traders work on the floor of the New York Stock Exchange on July 12, 2023 in New York City.Spencer Platt/Getty Images

As long-standing recession alarms continue to blare from some forecasters, investors don’t appear to hear them.

The S&P 500 this year, when excluding the ten largest companies, stands at single-digit gains.

Looking ahead, Agati and Moya said they expect the stock market to decline over the remainder of the year, ending 2023 with positive but modest returns. The full economic cooling-off effects of central bank rate hikes have yet to take hold, they said, adding that inflation may not return to normal levels as soon as investors hope.

"The rally will stall out here," Moya said.

MORE: US economy 'quite resilient,' Fed Chair Jerome Powell says

Stoltzfus, however, said there's a "good chance" the stock market will end the year higher than it currently stands.

"We have maintained a fairly bullish posture," he said. "Where the market is trading right now would suggest to us that it has further to go this year."

Previous article： Alkermes shareholders re
Next article： Arena BioWorks launches in Cambridge to speed drug discovery

hotspot

WSS

Neutralizing antibodies against HIV shows promise in children

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

House panel to mark up pandemic

With fresh data, a dynamic duo powers Eli Lilly to new heights

A preacher's new calling: Diversifying neuroscience research

focus

knowledge

MORE: US economy 'quite resilient,' Fed Chair Jerome Powell says

knowledge

Alkermes shareholders re

Hospital chaplains balance Covid safety with patients’ spiritual needs

Moonlake's readout produced a cash windfall. Risks remain

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Hepatitis C has a cure — but many Americans still lack access to it

With fresh data, a dynamic duo powers Eli Lilly to new heights

At least 13 dead in Texas as scorching temps continue

The PBM ad wars are taking over Washington, D.C.

Medicare proposal to cover medical devices draws a mixed reaction

Why Titanic fascinates society, still drawing tours to the wreckage

focus

Stories you might have missed in 2023: health, science, medicine

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Neutralizing antibodies against HIV shows promise in children

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Arena BioWorks launches in Cambridge to speed drug discovery

FDA approves Leqembi, a milestone in Alzheimer’s treatment

entertainment

hotspot

focus

focus